Carbone Cancer Center members recognized as Vilas Professors
Three UW Carbone Cancer Center members recently earned Vilas Professorships.
New method of viral maintenance in cancer cells identified in UW study
A new method for how viruses ensure their maintenance in dividing cells has been identified by researchers at the University of Wisconsin McArdle Laboratory for Cancer Research and Carbone Cancer Center.
Study links insurance coverage to higher rates of colorectal cancer screenings
As the nation debates whether and how health insurance should be reformed, researchers at the University of Wisconsin School of Medicine and Public Health determined that people with a certain type of insurance policy were more likely to be screened for colorectal cancer.
Viral infection found to increase therapeutic resistance of glioblastoma cells
A common human virus, cytomegalovirus (CMV), can convert glioblastoma (GBM) brain cancer cells into cancer stem cells with higher therapeutic resistance, according to a new study by University of Wisconsin Carbone Cancer Center researchers.
Study sheds light on function of protein associated with high-risk breast cancers
The function of a protein associated with breast cancer development and metastasis is now better understood, based on a new study by University of Wisconsin Carbone Cancer Center (UWCCC) researchers.
Immunotherapy: Harnessing cellular systems to fight deadly diseases
Four decades ago, researchers at the University of Wisconsin School of Medicine and Public Health had the right idea—to pursue a theory that they could harness patients’ own immune systems to fight and defeat cancer. Their perseverance and hard work are paying off, as they’ve recently made great strides in cellular immunotherapy, along with colleagues in myriad medical fields.
Paul Sondel wins prestigious award for pioneering cancer research
Alumni profile: Paul Sondel, MD, PhD ’75
Years of hard work are sandwiched between where Paul Sondel, MD, PhD ’75, is today and his humble beginnings in the medical field – washing test tubes.
Aly Wolff’s dream lives on with new clinical trial
Aly Wolff died of neuroendocrine cancer on April 22, 2013, however her courageous battle continues. Today, three years later, a new clinical trial at the University of Wisconsin Carbone Cancer Center has been approved and holds great promise in offering a new line of treatment for those with neuroendocrine tumors.
Fiore, Sondel chosen for prestigious new grant program in cancer research
The National Cancer Institute (NCI) has selected two UW-Madison faculty, Dr. Michael Fiore and Dr. Paul Sondel, as inaugural recipients of an Outstanding Investigator Award, which provides seven years of research support to investigators with outstanding records of productivity and achievement in cancer research.